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Objective: To evaluate the ameliorator property of silymarin or/and Nigella sativa
(N. sativa) extract against N-acetyl-p-aminophenol (APAP)-induced injury in male mice
at the biochemical, histological and ultrastructural levels.
Methods: The mice were divided into seven groups (10/group). The ﬁrst group was
served as control. While, the second group was treated with dose of APAP. The third and
fourth groups were treated with silymarin alone and N. sativa extract alone respectively.
The ﬁfth and sixth groups were treated with combination of APAP with silymarin and
APAP with N. sativa extract respectively. The seventh group was treated with combi-
nation of both ameliorative compounds (silymarin and N. sativa extract) with APAP and
all animals were treated for a period of 30 days.
Results: Exposure to APAP at the treated dose to mice led to an alteration of liver
functions, increased the alanine transaminase, aspartate aminotransferase and lactate
dehydrogenase levels, decreased total protein level as well as increasing the superoxide
dismutase and malondialdehyde while decreased catalase, glutathione peroxidase and
glutathione reduced activities. The levels of APAP on the biochemical parameters of mice
were dose-dependent. Administration of silymarin or/and N. sativa extract to APAP-
treated mice attenuates the toxicity of this compound, objectiﬁed by biochemical, his-
tological and ultrastructural improvement of liver. But the alleviation was more pro-
nounced with the both antioxidants.
Conclusions: The synergistic effect of silymarin and N. sativa extract is the most
powerful in reducing the toxicity induced by APAP and improving the liver functions and
antioxidant capacities of mice.1. Introduction
The liver is the most signiﬁcant organ of our body for
detoxiﬁcation; disorders to this organ remain some of the most
serious health problems[1]. Liver diseases remain to be serious
health problems and the management of liver disease is still a
challenge to the modern medicine. Liver plays an essential
role in regulation of physiological processes, involved in
several vital functions such as storage, secretion and
metabolism. It also detoxiﬁes a variety of drugs and
xenobiotics and plays a central role in transforming, clearingthe chemicals and is susceptible to the toxicity from these
agents[2].
Hepatotoxicity is a common cause of severe metabolic dis-
orders and even death[3]. Hepatic damage occurs due to its
multi-dimensional functions, various xenobiotics and oxidative
stress leading to distortion of all of its functions[4].
Acetaminophen [paracetamol or N-acetyl-p-aminophenol
(APAP)] is a derivative of para-aminophenol used as an anal-
gesic and antipyretic drug belonging to the para-aminophenol
class of the nonsteroidal anti-inﬂammatory drugs[5].
APAP (paracetamol) produces acute liver damage at very
larger dose. The hepatotoxicity of APAP has been attributed to the
formation of toxic highly reactive metabolite N-acetyl-p-benzo-
quinone imine (NAPQI) which causes oxidative stress and
glutathione depletion[6]. It is a well-known antipyretic and anal-
gesic agent, which produces hepatic necrosis at higher doses[7].n open access article under the CC BY-NC-ND
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liver to excretable glucuronide and sulphate conjugates[8]. The
hepatotoxicity of APAP has been attributed to the formation
of toxic metabolites when part of it is activated by hepatic
cytochrome P-450 to form the highly reactive metabolite
(NAPQI). Accidental or intentional intake of high doses often
causes acute hepatocellular necrosis with high morbidity and
mortality[9].
Nigella sativa L. (Ranunculaceae) (N. sativa), commonly
known as “black cumin”, is an erect herbaceous annual plant. It
grows in Mediterranean countries and is also cultivated in the
north of Morocco. N. sativa seeds have traditionally been used in
Middle Eastern folk medicine as a natural remedy for various
diseases as well as a spice for over 2000 years. The seeds of
N. sativa have been subjected to a range of pharmacological,
phytochemical and nutritional investigations in recent years. It
has been shown to contain more than 30% (w/w) of a ﬁxed oil
with 85% of total unsaturated fatty acid[10]. The protective role
of the black seed oil against hepatotoxicity has been investigated
in animal experiments[11]. N. sativa oil (0.27 g/100 g body
weight/day) was administered into adult rats and the treated
animals showed decrease in serum (gamma-glutamyl
transferase) nuclear DNA content which was elevated in the
control group of the animals.
Silymarin contains a number of active constituents called
ﬂavolignans which are also used to help protect the liver from
poisoning[12]. Silybum marianum (milk thistle) has been used to
treat liver diseases since the 16th century. Its major constituents
are ﬂavonoids, silibinin, silidianin, silichristin and isosilibinin of
which silibinin is the biologically most active compound and
used for standardisation of pharmaceutical products[13].
The pharmacological proﬁle of silymarin has been well
deﬁned and hepatoprotective properties of silymarin were
investigated both in vitro and in vivo. Experimental studies
demonstrated antioxidant and free radical scavenging properties,
improvement of the antioxidative defence by prevention of
glutathione depletion and anti-ﬁbrotic activity[13].
Therefore, the present study was undertaken to evaluate the
ameliorator property of silymarin or/and N. sativa extract on
toxic status during APAP-induced injury in male mice at the
biochemical, histological and ultrastructure levels.
2. Materials and methods
2.1. Chemicals
APAP was purchased from the Egyptian International Phar-
maceutical Industries Company; silymarin was obtained from
Sedeco Pharmaceutical Co-6-october City, Egypt. The N. sativa
seeds were purchased from a local herb store with a fair degree
of quality assurance. Seeds were washed to remove sand and
other debris and air-dried and ﬁnely powdered with an electric
microniser according to traditional mode of preparation[14].
Crude extract was obtained by the maceration of 800 g of
these seeds by boiling in distilled water (1200 mL) for 24 h
and ﬁltered through muslin[15] and each 1 mL of the extract
will contain 0.6 g of N. sativa. After 24 h, the aqueous extract
was ﬁltered and concentrated at room temperature, then the
dried extract was stored at 4 C until use[16]. Other chemicals
and reagents were of the highest analytical grade and were
bought from standard commercial suppliers in Roche
(Germany).2.2. Animals
ICR male mice, weighing approximately 35–40 g were
provided by Faculty of Veterinary Medicine, Zagazig Univer-
sity. The animals were maintained in solid bottom shoe box-
type polycarbonate cages with stainless steel wire-bar lids,
using a wooden dust-free litter as a bedding material. Animals
were located in air-conditioned room and were allowed free
access to pellet diet and tap water for a week before starting the
experiment. The European Community Directive (86/609/
EEC) and national rules on animal care have been followed.
After 2 weeks of acclimation, animals were randomly divided
into seven groups with 10 animals in each one as following:
Group 1 was served as untreated control (1 mL/kg of physio-
logical saline); Group 2 was treated with paracetamol (2 g/kg)
[17]; Group 3 was treated with silymarin (50 mg/kg)[18]; Group
4 was treated with N. sativa extract (0.25 g/Kg) (0.5 mL of the
prepared solution)[14]; Group 5 was treated with paracetamol
and silymarin; Group 6 was treated with paracetamol and
N. sativa and the ﬁnal Group 7 was treated with combination
of both ameliorative compounds (silymarin and N. sativa
extract) with paracetamol. All the groups were treated orally
for 30 successive days.
2.3. Collection of blood samples
At the end of experimental period, blood samples of the
fasted mice were collected from the medial retro-orbital venous
plexus immediately with capillary tubes (Micro Hematocrit
Capillaries, Mucaps) under ether anesthesia[19]. Then, the blood
was centrifuged at 3000 r/min for 15 min and serum was
collected for different biochemical analyses.
2.4. Hepatic biomarkers determination
Serum aspartate transaminase (AST) and alanine trans-
aminase (ALT) activities were determined with kits from Human
Diagnostic Worldwide, Germany.
2.5. Preparation of tissues for measurement of
oxidative/antioxidant parameters
The tissues of liver and kidney were used for the analysis of
oxidative stress and antioxidant parameters. Prior to dissection,
tissue was perfused with 50 mmol/L sodium phosphate buffer
saline (100 mmol/L Na2HPO4/NaH2PO4) (pH 7.4) and
0.1 mmol/L ethylenediaminetetraacetic acid to remove any red
blood cells and clots. Then tissues were homogenized in 5 mL
cold buffer/g tissue by a Potter–Elvehjem type homogenizer.
The homogenate was centrifuged at 10 000 r/min for 20 min at
4 C, and the resultant supernatant was transferred into Eppen-
dorf tubes and preserved in a deep freezer until used. The su-
pernatant was used for the determination of some biochemical
parameters of liver and kidney tissues.
2.6. Lipid peroxidation assay
The extent of lipid peroxidation was estimated as the con-
centration of thiobarbituric acid reactive product malondialde-
hyde (MDA) by using the method of Ohkawa et al.[20].
Malondialdehyde concentrations were determined using
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cromoles per gram of tissue.
2.7. Antioxidant enzymes
Superoxide dismutase (SOD) activity was measured accord-
ing to the method described by Marklund and Marklund in
which pyrogallol underwent autoxidation at 440 nm for 3 min
[21]. One unit of SOD activity was calculated as the amount of
protein that caused 50% pyrogallol autoxidation inhibition.
The SOD activity was expressed as units per gram tissue.
Before determination of the catalase activity, samples were
diluted 1:9 with 1% Triton X-100 (v/v). Catalase activity was
measured according to the method described by Aebi[22]. The
hydrolysis of H2O2 and the resulting decrease in absorbance at
240 nm over a 3 min period at 25 C was measured. Catalase
activity was expressed as units per gram tissue.
2.8. Measurement of enzymes involved in glutathione
metabolism
The glutathione peroxidase (GPX) activity was measured by
the method of Hafeman et al.[23]. The reaction mixture contained
0.5 mL of 0.4 mol/L sodium phosphate buffer (pH 7.0) and
0.4 mmol/L ethylenediaminetetraacetic acid, supplemented
with 0.25 mL of sodium azide (1 mmol/L), 0.5 mL of
glutathione (2 mmol/L) and 0.25 mL of distal water. About
0.5 mL of homogenate was added and allowed to equilibrate
for 5 min at 37 C. The reaction was initiated by adding
0.5 mL of H2O2 (1.25 mmol/L). Absorbance at 340 nm was
recorded at 1, 3, and 6 min. The activity of GPX was
expressed in terms of nanomoles glutathione consumed per
minute per gram of tissue (IU/g).
The glutathione reduced activity was measured by the
method of Hafeman et al.[23]. The reaction mixture contained
1.2 mL of 67 mmol/L sodium phosphate buffer (pH 7.0),
0.2 mL of sodium azide (1 mmol/L) and 0.1 mL of oxidized
glutathione (7.5 mmol/L). Homogenate (0.5 mL) was added
and allowed to equilibrate for 5 min at 37 C. Reaction was
initiated by adding 0.25 mL of reduced nicotinamide adenine
dinucleotide phosphate (2 mmol/L). Absorbance at 340 nm
was recorded at 1, 2 and 3 min. The activity of glutathione
reduced was expressed in terms of micromoles-mol gluta-
thione produced per minute per gram of tissue (IU/g).
2.9. Histological evaluations
Histological examination of the tissues was conducted after
removal of liver tissues from mice. The tissues were gently rinsed
with a physiological saline solution (0.9% NaCl) to remove blood
and adhering debris. They were then ﬁxed in 5% formalin for
24 h, and the ﬁxative was removed by washing overnight with
running tap water. After dehydration through a graded series of
alcohols, the tissues were cleared in methyl benzoate and
embedded in parafﬁn. Sections were cut by a microtome at 6 mm
thickness and stained with Hematoxylin staining as described by
Gabe and counter stained with eosin dissolved in 95% ethanol
(Hematoxylin and Eosin stain)[24]. After dehydration and
clearing, sections were mounted with digital picture exchange
and observed under a microscope. The histopathological
examination was performed according to Lobenhofer et al.[25].2.10. Ultrastructure examination
Liver was cut into small pieces of about 1–3 mm in size and
immediately ﬁxed in 2.5% glutaraldehyde for 24–48 h. The
specimens were then washed in phosphate buffer (pH 7.2–7.4)
3–4 times for 20 min every time and post-ﬁxed in a buffered
solution of 1% osmium tetraoxide for 2 h, after that they were
washed in the same buffer 4 times for 20 min each. Fixed
specimens were dehydrated in ascending grades of ethyl alcohol
(30%, 50%, 70%, 90% and 100%), cleared in two changes of
propylene oxide, and embedded in Epon resin[26]. Semithin
sections (1 mm thick) were stained with toluidine blue for
2 min and examined by the use of a light microscope. The
resin blocks were retrimmed to get rid of the undesired tissue.
Ultrathin sections (60–90 nm thick) and representative ﬁelds
of semithin sections were selected and were cut with a
diamond knife using a Reichert OMVs ultramicrotome,
mounted on copper grids and double stained with uranyl
acetate and lead citrate. The grids were examined and
photographed using a transmission electron microscope (JEOL
JEM-1200 EX II, Japan) operated at 60–70 kV, Faculty of
Agriculture (Electron Microscope Unit), Mansora University.
2.11. Statistical analysis
Statistical analysis was performed using SPSS for Windows
version 17.0. Data were given in the form of arithmetical
mean ± SE. Differences between groups were evaluated by One-
way ANOVA according to P < 0.05 and post-hoc Duncan test.
For each histological parameter, a score has to be performed for
analyzing a number of different histological sections in each
organ for each animal and then the median value has to be
calculated for each group; ﬁnally a comparison could be done by
a semi-quantitative test using SPSS.
3. Results
3.1. Biomarkers of liver assessments
The total protein content decreased in paracetamol treated
group depending on the dose, but increased by 36.45 and 38.14
fold in the groups treated with the silymarin and N. sativa extract
respectively when compared with control group (Table 1).
Meanwhile combination of paracetamol, silymarin and N. sativa
extract has ameliorated total protein content as compared with
control group. Serum ALT activity of silymarin and N. sativa
extract groups was nonsigniﬁcantly increased by 5.79% and
1.5%, when compared with control group. In the paracetamol-
treated groups, the ALT was increased by 85.71 fold as the
dose increase when compared to control. Treatment the mice
with 1000 mg/kg paracetamol with the combination of silymarin
and N. sativa extract decreased the activity of ALT more than
each compound separately. The same observation has been
noticed in the AST and alkaline phosphatase (ALP) activities
that increased by giving the dose of paracetamol and decreased
by the treatment of each antioxidant separately.
To investigate the hepatic cells integrity, we measured lactate
dehydrogenase (LDH) activity (Table 1). It represents the
marked elevation in serum LDH in paracetamol treated group by
83.85 fold as compared to control group, while groups treated
with either silymarin or N. sativa showed nonsigniﬁcant changes
Table 1
Changes of serum liver functions in male mice treated with silymarin, N. sativa extract and paracetamol separately or in combination.
Groups Total protein (g/dL) AST (IU/mL) ALT (IU/mL) LDH (mIU/mL)
Control group 7.48 ± 0.27b 12.20 ± 0.58e 13.00 ± 0.70e 271.66 ± 47.21ef
Acetaminophen (paracetamol) 4.88 ± 0.40e 167.80 ± 7.39a 91.00 ± 1.18a 1628.40 ± 35.37a
Silymarin 7.68 ± 0.44b 13.80 ± 6.02de 13.80 ± 1.82de 270.30 ± 33.34ef
N. sativa extract 7.89 ± 0.63ab 13.10 ± 1.01de 13.20 ± 2.10e 265.32 ± 14.06f
Acetaminophen + silymarin 5.76 ± 0.65d 75.00 ± 1.67b 53.20 ± 0.86b 720.00 ± 30.37c
Acetaminophen + N. sativa extract 5.24 ± 0.51d 76.40 ± 3.12b 55.40 ± 0.50b 762.66 ± 50.63bc
Acetaminophen + silymarin + N. sativa extract 7.02 ± 0.16c 64.20 ± 4.61c 45.60 ± 2.73c 620.31 ± 51.26d
Means within the same column in each category carrying different letters are signiﬁcant at P  0.05 using Duncan's multiple range test, where the
highest mean value has symbol (a) and decreasing in value were assigned alphabetically.
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best ameliorative LDH value was recorded in group treated with
both silymarin and N. sativa extract with paracetamol.
3.2. Oxidative and antioxidant responses
As shown in Table 2, the data showed that treatment with
paracetamol caused a signiﬁcant decrease in the activity of SOD in
liver and kidney. Administration of silymarin caused nonsigniﬁ-
cant increase in SOD activity in liver and kidney tissues as
compared with those of control mice. In addition, a signiﬁcant
recovery relating to SODwas observed in response to the presence
of either silymarin orN. sativa extract or both with paracetamol in
all tested tissues. Treatment of the mice with silymarin and
N. sativa extract nonsigniﬁcantly increased SOD and slightly
decreased the SOD activity of liver and kidney tissues respec-
tively. However, co-administration of silymarin or N. sativa
extract with paracetamol increased the SOD activity in tested
tissues but still better than administration of paracetamol alone.
The catalase activity decreased after paracetamol treatment in
all examined tissues. The administration of either silymarin or
N. sativa extract increased the catalase activity in liver and
kidney tissues as compared with the paracetamol group. The
treatment of the mice with silymarin and N. sativa extract in
combination with paracetamol elevated the catalase activity in
liver and kidney tissues as compared with
paracetamol + silymarin or paracetamol + N. sativa extract.
The activity of GPX was signiﬁcantly decreased in liver and
kidney tissues of mice treated with paracetamol by 75.24% and
71.34% as compared with the control group, respectively
(Tables 2 and 3). Treatment of the animals with silymarin or
N. sativa extract alone caused signiﬁcant changes in the activity
of this enzyme as they elevated this enzyme as compared with
control group. While the presence of silymarin or N. sativaTable 2
Changes in SOD, catalase, malondialdehyde, GR and GPX activities of live
separately or in combination.
Groups SOD (IU/g) C
Control group 12.41 ± 1.79e 4.
Acetaminophen (paracetamol) 25.59 ± 1.22a 1.
Silymarin 12.76 ± 1.51e 4.
N. sativa extract 11.66 ± 1.18f 4.
Acetaminophen + silymarin 18.62 ± 1.22c 2.
Acetaminophen + N. sativa extract 19.05 ± 1.24b 2.
Acetaminophen + silymarin + N. sativa extract 15.25 ± 1.03d 3.
GR: Glutathione reductase; CAT: Catalase; MDA: Malondialdehyde. Means
niﬁcant at (P 0.05) usingDuncan'smultiple range test, where the highestmeanextract in combination with paracetamol minimized the observed
alterations in the examined enzyme activity induced by para-
cetamol intoxication in all examined tissues. Thus there was
elevation in GPX activity after administration of both silymarin
and N. sativa extract, respectively.
As shown in Tables 2 and 3, treatment of the mice with para-
cetamol caused a signiﬁcant decrease (P < 0.05) in the activity of
glutathione reduced levels in liver and kidney tissues by 75.24 and
71.34 fold as compared with control animals, respectively.
Administration of silymarin or N. sativa extract alone caused
nonsigniﬁcant changes and slight decrease in glutathione activity
respectively as compared with control mice. In addition, a sig-
niﬁcant recovery relating to glutathione reduced was observed in
response to the presence of silymarin and N. sativa extract in
combination with paracetamol which showed amelioration in the
enzyme activity as comparedwith paracetamol treated group only.
3.3. Histopathological investigations of liver tissues
Figure 1 depicts photomicrographs of Hematoxylin-Eosin
stained liver tissues of control and experimental groups of
mice. Figure 1A shows the section of liver tissue from control
mice, demonstrating normal histology with normal central vein
and normal hepatic lobule. Similarly, the sections of liver tissues
from mice treated with silymarin alone also revealed normal
liver tissue formed of central vein surrounded by cords of he-
patocytes with normal vesicular nuclei and eosinophilic cyto-
plasm (Figure 1D) and group treated with N. sativa extract
showed normal central vein surrounded by cords of hepatocytes
(Figure 1E). Mice liver treated with paracetamol showed
markedly dilated congested central vein (orange arrow) ﬁlled by
large number of red blood cells and surrounded by hepatic cords
with congested dilated central parts of sinusoids and markedly
pyknotic nuclei and focal hepatocytes necrosis with drop offr in male mice treated with silymarin, N. sativa extract and paracetamol
AT (IU/g) MDA (nmol/g) GR (IU/g) GPX (IU/g)
49 ± 0.01b 1.74 ± 0.10f 6.91 ± 0.75a 8.04 ± 0.74b
52 ± 0.03f 12.35 ± 0.26a 1.12 ± 0.48e 1.99 ± 0.51f
53 ± 0.03b 1.50 ± 0.66g 6.99 ± 0.58a 8.64 ± 0.44ab
63 ± 0.04ab 2.91 ± 0.12e 5.30 ± 0.94c 6.50 ± 1.34c
57 ± 0.04e 7.30 ± 0.25c 3.01 ± 0.82d 4.89 ± 0.82e
72 ± 0.05de 7.38 ± 0.38bc 3.03 ± 1.56d 4.83 ± 1.00e
95 ± 0.02c 5.04 ± 0.26d 5.77 ± 1.19bc 5.70 ± 1.13d
within the same column in each category carrying different letters are sig-
value has symbol (a) and decreasing in value were assigned alphabetically.
Figure 1. Photomicrographs of liver sections of control and experimental mice stained with Hematoxylin-Eosin under light microscopy.
Table 3
Changes in SOD, catalase, malondialdehyde, GR and GPX activities of kidney in male mice treated with silymarin, N. sativa extract and paracetamol
separately or in combination.
Groups SOD (IU/g) CAT (IU/g) MDA (nmol/g) GR (IU/g) GPX (IU/g)
Control group 23.32 ± 0.87d 5.49 ± 0.05ab 8.67 ± 0.02f 6.41 ± 0.50a 5.13 ± 0.36b
Acetaminophen (paracetamol) 29.61 ± 1.52c 1.31 ± 0.04e 38.68 ± 0.42a 1.62 ± 0.30e 1.47 ± 0.36f
Silymarin 22.14 ± 2.98e 5.28 ± 0.07b 8.60 ± 0.18f 6.50 ± 0.43a 5.32 ± 0.40ab
N. sativa extract 18.82 ± 0.91f 5.11 ± 0.01b 9.42 ± 0.01e 5.31 ± 0.38b 4.27 ± 0.43c
Acetaminophen + silymarin 34.94 ± 1.66a 4.51 ± 0.07d 14.79 ± 0.03c 3.25 ± 0.92d 2.25 ± 0.92e
Acetaminophen + N. sativa extract 34.92 ± 1.59a 4.47 ± 0.07d 18.27 ± 0.15b 3.41 ± 0.29d 2.41 ± 0.29e
Acetaminophen + silymarin + N. sativa extract 31.91 ± 0.88b 4.94 ± 0.08c 10.59 ± 0.05d 4.20 ± 0.53c 3.20 ± 0.53d
Means within the same column in each category carrying different letters are signiﬁcant at (P  0.05) using Duncan's multiple range test, where the
highest mean value has symbol (a) and decreasing in value were assigned alphabetically.
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liver tissue from paracetamol-treated mice in combination with
silymarin, exhibiting swollen hepatocytes with foamy ﬁnely
granular cytoplasm. Group treated with paracetamol and
N. sativa extract showed cords of hepatocytes with mild con-
gested sinusoids (Figure 1G). Treatment of the mice with
paracetamol with silymarin and N. sativa extract showed mild
lobular inﬂammation with few scattered intra lobular aggregates
of chronic non-speciﬁc inﬂammatory cells (Figure 1H).Figure 2. Electron micrographs of liver sections of control and experimental m
N: Nucleus; M: Mitochondria; GL: glycogen inclusions; LP: Lipid droplet; LY3.4. Ultrastructure investigations of liver tissues
Figure 2 depicts electron micrographs of liver tissues of
control and experimental groups of mice. Figure 2A shows the
section of liver tissue from control mice, demonstrating part of
the nucleus, mitochondria, rough endoplasmic reticulum (RER),
glycogen inclusions and lipid droplet (scale bar 10 mm).
Figure 2B shows mice liver treated with paracetamol showing
irregular nuclei (red arrow) with some pyknosis in nuclei withice.
: lysosomes; V: vacuoles.
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and showing nearly disintegration of most of cellular contents
(black arrow) except few number of mitochondria, (scale bar
5 mm). Figure 2C shows liver of silymarin treated group dis-
played normal cell organelles: nucleus, mitochondria, RER and
normal cell membrane (scale bar 2 mm). Figure 2D shows the
section of liver tissue from N. sativa group, demonstrating
normal appearance of nucleus, RER, mitochondria and glycogen
rosettes (scale bar 2 mm). Figure 2E portrays samples of liver
tissue of paracetamol-treated mice in combination with sily-
marin, exhibiting irregular nucleus but with ameliorative
appearance than acetaminophen treated group, depris mito-
chondria, lysosomes and RER (scale bar 2 mm). Figure 2F of
group treated with paracetamol and N. sativa extract shows little
depris mitochondria, vacuoles, normal glycogen rosettes and
regular nucleus (scale bar 2 mm). Treatment of the mice with
paracetamol with silymarin and N. sativa extract showed nearly
normal appearance of binuclei with smaller size (black arrow),
one pyknotic nuclei (red arrow), nearly small mitochondria and
nearly restoration of some distingerated cell contents (scale bar
10 mm) (Figure 2G).
4. Discussion
The major goal of this work was to evaluate the potential
beneﬁt of silymarin and N. sativa extract administration on
APAP tissue injury, compared to silymarin or N. sativa extract
treatment alone. To our knowledge, no study has been con-
ducted on the co-effect of silymarin and N. sativa extract on
APAP toxicity at the biochemical, histopathological and ultra-
structural levels for the liver as well as antioxidant parameters of
the mice. This study investigated the ability of silymarin and
N. sativa extract to counteract APAP-induced toxicity in mice.
Exposure to APAP at the tested dose to mice led to an alteration
of liver functions and antioxidant capacities, decreased the total
protein, increased ALT, AST and LDH levels as well as
increased MDA and SOD while decreased catalase, GPX and
GR. The biochemical and oxidative changes in APAP-treated
groups were dose dependent. Concomitant administration of
silymarin or/and N. sativa extract with APAP signiﬁcantly
protected most of the altered biochemical and antioxidant vari-
ables induced by APAP suggesting their protective efﬁcacy.
These two antioxidant compounds also improved the structure of
vital organ (liver) that was evaluated on the basis of histopath-
ological and ultrastructure ﬁndings. The biochemical markers
used to evaluate liver function were ALT, AST, total protein and
LDH. ALT and AST are the most sensitive biomarkers directly
implicated in the extent of hepatic damage and toxicity[27,28].
Our results showed that levels of serum transferases (AST
and ALT) were markedly elevated by acetaminophen (paracet-
amol) administration to mice when compared with control
group. Acetaminophen (paracetamol) in its recommended doses
elicited a marked elevation in serum LDH activity after the end
of the study when compared with control group. ALT, AST and
LDH are important indicators of liver damage in clinical ﬁnd-
ings. These enzymes were secreted into the blood in hepato-
cellular injury and their levels increase. Changes in these
enzyme levels might differ depending on exposure time and
dose.
Our results are reinforced by Mossa et al. as they noticed the
increase in the levels of aminotransferase (ALT and AST) and
the level of ALP as well as the decrease in the levels of totalprotein and albumin (are the major diagnostic symptoms of liver
diseases) in the serum of paracetamol treated group[29].
Our results are reinforced by Yousef et al. who reported that
paracetamol-induced hepatocellular necrosis marked by
increased plasma AST, ALT, ALP and LDH activities[30].
Paracetamol also decreased plasma total protein as reported in
our results.
The liver is the major source of most of the serum proteins, in
which the parenchymal cells are responsible for synthesis of
albumin, ﬁbrinogen and other coagulation factors and most of
the a and b globulins[31]. Albumin, being the most abundant
plasma protein, accounts for 60% of the total serum protein
and is incorporated in many physiological processes. The
observed decrease in albumin by paracetamol, which is
consequently reﬂected the decrease in total protein, could be a
result of a decline in the number of cells responsible for
albumin synthesis in the liver through necrosis on the same
grounds. This explains the decline in total protein in our study
after treatment of mice with paracetamol for 30 successive
days[32].
Paracetamol overdose can cause liver function failure and
death in human as well as experimental animals which is in
agreement with our results and this could be due to the formation
of highly reactive radicals because of oxidative threat caused by
paracetamol[33].
Our results are also supported by Hawkins et al. who showed
that paracetamol could in severe cases lead to liver failure in
experimental animals and humans when taken in overdose[34].
The mechanisms of polyarylamide hepatotoxicity have been
extensively studied[35]. The initial step in toxicity is
cytochrome P450 metabolism of acetaminophen to the reactive
metabolite NAPQI. NAPQI is an electrophilic intermediate,
which is oxidized by cytochrome P450 and converted to a
highly reactive and toxic metabolite as in cases of APAP
overdose[36].
NAPQI can rapidly react with glutathione and lead to 90% of
total hepatic glutathione depletion in cells and mitochondria,
which can result in hepatocellular death and mitochondrial
dysfunction. NAPQI can also induce DNA strand breaks and
promote apoptosis and hepatic necrosis[37].
LDH is localized in the cytoplasm of cells and thus is
extruded into the serum when cells are damaged or necrotic. The
measurement of total LDH can be useful when only a speciﬁc
organ, such as the liver, is known to be involved. LDH is
increased in acute necrosis of the liver. LDH is a sensitive
intracellular enzyme which increases in serum and is an indi-
cation of liver cell damage and this supports our obtained ﬁnding
that recorded increment in LDH level in paracetamol treated
group[38].
Our results showed that acetaminophen (paracetamol) when
given daily for successive 30 days afforded a signiﬁcant increase
in serum ALT activity post drug administration along the entire
period of the experiment when compared with control group.
Our results seem to be conceivable with that obtained by
Greenlee et al.[39] and Tamayo and Diamond[40]. They reported
that milk thistle (silymarin) have protective effects on the liver
and greatly improve its function since it is typically used to
treat liver cirrhosis and chronic hepatitis (liver inﬂammation).
In addition, milk thistle extract prevent and repair damage
from toxic chemicals and medications. Workers who had been
exposed to vapors from toxic chemicals for 5–20 years which
were given silymarin for 30 days. They showed signiﬁcant
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counts[41]. The liver regenerating effect induced by silymarin
results from stimulation of RNA polymerase enzyme in the
nucleus of liver cells. This results in an increase of ribosomal
protein synthesis which helps to regenerate hepatocytes[42]. On
similar grounds, silymarin might also affect bone marrow.
The combination of acetaminophen (paracetamol) with either
N. sativa extract or silymarin afforded also a signiﬁcant eleva-
tion in serum ALT level after 4th weeks post-treatment but less
than increment recorded in paracetamol treated group indicating
that both N. sativa and silymarin succeed to some extent in
correcting the effect produced by acetaminophen (paracetamol).
Either silymarin or N. sativa extract caused a signiﬁcant
reduction in the elevated serum transaminases activity along the
entire course of the study when compared with acetaminophen
group alone. This plant drug and plant extract succeeded in
improving the status of injured liver caused by acetaminophen.
Chopra et al.[43], and Rooney and Ryan[44] reported that
thymoquinone, one of the active constituents of N. sativa has
a hepatoprotective activity. An in vitro study showed the
protective effect of N. sativa against tert-butyl hydroperoxide
induced oxidative damage to hepatocytes. The activity was
demonstrated by a decreased leakage of ALT and AST.
The hepatoprotective effect of N. sativa was supported also
by the results of Mahmoud et al.[45]. The same previous effects
were observed on serum AST level with the exception of effects
of N. sativa, silymarin and their combination with
acetaminophen (paracetamol) which showed some elevation
when compared with control group. This may be attributed to
the fact that AST is not a liver speciﬁc enzyme.
Our results coincide also with Al-Anati et al.[41]. They
reported that milk thistle (silymarin) repair damage caused by
toxic chemicals and medications. They exposed workers to
vapors from toxic chemicals (toluene and/or xylene) for 5–20
years who were given either a standardized milk thistle (80%
silymarin) for 30 days. The workers showed signiﬁcant
improvement in liver function tests (ALT and AST) when
compared with placebo.
On the same basis, milk thistle (silymarin) is used primarily
to treat various liver diseases and dysfunctions including alco-
holic cirrhosis, hepatitis (due to viral infection or drug–induced)
as well as hepatic problems related to diabetes[43]. Silymarin has
liver regenerative effects by stimulating the enzyme known as
RNA polymerase in the nucleus of liver cells. This results in
an increase of ribosomal protein synthesis which helps to
regenerate hepatocytes[43].
Our result was in accordance with Floyd et al. as previously
mentioned with serum ALT and AST[46]. At the meantime, it
was obvious that acetaminophen afforded a signiﬁcant
elevation in serum LDH activity when compared with control
group along the entire period of the experiment. The
administration of acetaminophen (paracetamol) for 30
successive days afforded also a more profound elevation in
serum LDH level when compared with both silymarin and
N. sativa extract group. The combination of acetaminophen
(paracetamol) with either N. sativa or silymarin afforded slight
signiﬁcant increase in the enzyme activity.
Concerning the effect on serum total proteins, our results
revealed that acetaminophen (paracetamol) induced signiﬁcant
decrease along the course of the study post drug administration
when compared with normal control group. Whereas, silymarin
induced nonsigniﬁcant elevation in serum total proteins after theend of the 4th week post-drug administration as well as N. sativa
induced when compared with normal control group. Meanwhile,
the combination of acetaminophen (paracetamol) and N. sativa
afforded a marked decrease in serum total proteins of the normal
group along the entire course of the experiment. The signiﬁcant
decrease in serum total proteins induced after the 4th week by
acetaminophen (paracetamol) post-drug administration coincides
with Forbes et al.[47]. They stated that a number of factors had
been shown to regulate protein synthesis; the most important
factors are insulin excretion and plasma amino acids
concentration. Insulin has been shown to be a powerful
inhibitor of protein degradation in vivo. In addition it is
particularly noteworthy that those cirrhotic patients are
characterized by severe resistance to action of insulin on
glucose metabolism. As a result, there is higher probability to
protein degradation because of hindering insulin action. Our
result showed that acetaminophen (paracetamol) decreased
signiﬁcantly insulin level along the entire period of the study
giving further support to our ﬁndings.
About 90% of total hepatocyte enzymes represented by these
transaminases and among them high level of ALT is a better
index of liver injury as it resides only in hepatocytes rather than
AST which is inherent in liver parenchymal cells, blood and
cardiac/muscle cells. ALP resides in cells lining biliary duct of
livers, bone and placental tissue is elevated due to cholestasis
and increased biliary pressure and this coincides with our results
and refer to liver damage caused by paracetamol by high level of
ALT in paracetamol treated group[48].
The nonsigniﬁcant changes in serum total proteins induced
by silymarin after the end of the 4th week post-treatment coin-
cide with Balandrin et al.[49]. They reported that silymarin can
enter into the nucleus and act on RNA polymerase I enzyme
and the transcription of rRNA result in an increase of
ribosomal formation. This in turn hastens protein and DNA
synthesis which enhances the biosynthetic apparatus in the
cytoplasm, thus leading to an increase in the synthesis rate of
both structural and functional proteins. This action has
important therapeutic implication in the repair of damaged
hepatocytes and restoration of normal functions of the liver.
Moreover, Fe´her and Lengyel found that silymarin protects
liver in 3 ways: by enhancing DNA polymerase, stabilizing
cell membrane and scavenging free radicals[50]. Whereas,
silymarin stimulates DNA polymerase, increase synthesis of
ribosomal RNA and stimulates liver cell regeneration and it
stabilizes cellular membranes and increases the glutathione
content of liver[51].
The increased total protein content obtained in our study as a
result of administration of N. sativa or its combination with
acetaminophen (paracetamol) for 30 days into normal mice was
in full agreement with Haq et al.[52].
Our results showed that cross section of liver tissues from
group treated with acetaminophen (paracetamol) (1000 mg/kg)
markedly dilated congested central vein ﬁlled by large number
of red blood cells and surrounded by hepatic cords with con-
gested dilated central parts of sinusoids and markedly pyknotic
nuclei, focal hepatocytes necrosis with drop off hepatocytes and
markedly pyknotic nuclei.
Lipid droplet, the integrity of cellular membranes, leads to
the leakage of cytoplasmic enzymes[53]. Therefore, the increased
activities of liver enzymes in the present study could be due to
severe histopathological damages and hepatotoxicity of
paracetamol.
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observations indicated marked changes in the overall histo-
architecture of liver in response to paracetamol which could be
due to its toxic effects primarily by the generation of reactive
oxygen species (ROS), causing damage to the various mem-
brane components of the cell[29]. One consequence of oxidative
stress and lipid peroxidation is the formation of DNA adducts.
Since DNA is believed to be the target molecule for
carcinogens, endogenous DNA adducts are derived from
oxidative stress, lipid peroxidation, and other sources have
been proposed to contribute to the etiology of human cancers[54].
In accordance with our results, Mossa et al. observed that the
necrotic conditions observed in the liver of paracetamol treated
animals are in corroboration with the observed biochemical
changes, wherein an increased level of lipid peroxidation was
noticed[29]. Previous studies showed that paracetamol cause mild
focal hepatitis in the lobules and portal areas necrosis in rats and
hemorrhagic necrosis in humans mostly characterized by
pyknosis and eosinophilic cytoplasm which are greatly in
agreement with our results[55].
In accordance with our results, Ratnasooriya and Jayakody
showed that there was a signiﬁcant serum glutamic-oxaloacetic
transaminase elevation and moderate leucocyte inﬁltration of
the hepatic vessels, suggesting a damaging effect on the liver[56].
It has been indicated that paracetamol overdose causes liver
necrosis and failure.
In agreement with our results, administration of an overdose
of APAP (1.5 g/kg) to rats developed a signiﬁcant liver damage,
after 12 h, evident by marked increase in serum ALT, concur-
rently with the development of severe histopathological changes
in liver tissues. Our results are in the same line with Fujimura
et al. who showed that early histological alterations result from a
single large dose of acetaminophen in liver of rats showed
cytoplasmic swelling and followed by hydropic vacuolation and
necrosis[57].
Similar results were obtained by Wu et al. as they showed
that silymarin has therapeutic effects on the early stages of liver
damage, involving the reversal of fatty changes and a regression
of the liver morbid histopathology[58].
Similar ﬁndings were obtained by Gani and John as they
found absence of any adverse toxic effects of N. sativa extract in
the liver[59]. These ﬁndings suggested the possibility of N. sativa
extract being able to protect liver tissues and thus decrease the
leakage of the enzymes (AST, ALT and ALP) in to the
circulation.
In accordance with our results, El-kott et al. indicated that the
N. sativa treated group showed the liver sections nearly with
normal architectures and normal hepatocytes[60].
Our obtained results indicated that ultrastructure of liver
sections from paracetamol treated group shows irregular nuclei
with some pyknosis in nuclei with appeared nucleolus, appeared
mitochondria, fragmented RER and nearly disintegration of
most of cellular contents except few number of mitochondrias
and these ﬁndings are in harmony with Fujimura et al. as they
reported ultrastructurally, depletion of glycogen, degranulation
of RER and swelling or disruption of mitochondria were
observed with enlargement of mitochondria, loss of glycogen
granules and degranulation of RER in acetaminophen (paracet-
amol) treated group[57].
In agreement with Fujimura et al., they showed that the main
alteration in acetaminophen (paracetamol) treated rats was
prominent enlargement of mitochondria associated with othervarious mitochondrial alterations including irregular conﬁgura-
tions and deposition of some materials[57].
It has been demonstrated that acetaminophen is oxidized by
cytochrome P-450, producing an acetaminophen free radical and
hydrogen peroxide. In the presence of oxygen, the free radical
generates superoxide. On the other hand, mitochondrion as well
as endoplasmic reticulum and the plasma membrane are
considered to be acetaminophen hepatotoxicity target sites and
thus mitochondrial dysfunction is considered to result to acet-
aminophen hepatotoxicity[57].
Our results are in accordance with Wu et al. as they showed
signiﬁcant recovery of hepatocyte ultrastructure of the 6-week-
old HBx transgenic mice given with silymarin (300 mg/kg/d) for
2 weeks[58].
Previous studies by El-kott et al. reported that N. sativa
treated animals showed that some degree of mitochondrial
swelling with some variation and size was noticed and this
disagrees with our obtained results[60]. However, nuclear
structures along with bile canaliculus and other organelles are
normal in these animals and this agrees with our obtained
results. The protective potential of N. sativa in restoring the
altered hepatic histoarchitecture was close to the
histoarchitecture of normal animals.
Our results are reinforced by Yousef et al.[30]. They reported
that paracetamol treatment caused a signiﬁcant elevation in
thiobarbituric acid reactive substance levels with simultaneous
inhibition in the activities of antioxidant enzymes and
glutathione transferase (GST), GPX, SOD and catalase in rat
plasma, liver, kidney, brain, lung, heart and testis.
Furthermore, it decreased glutathione content signiﬁcantly in
rat liver, kidney and lung. These features might be attributed
to the metabolic activation of paracetamol, which is
considered a major mechanism of its toxicity.
In accordance with our results, Jaeschke et al.[61] and Newton
et al.[62] were found that paracetamol trigger a rapid loss of
glutathione and lipid peroxidation in both liver and kidney.
The basic mechanism of paracetamol toxicity in the liver is
the covalent binding of NAPQI, the reactive metabolite of
paracetamol, to sulfhydryl groups of glutathione and various
proteins and their subsequent oxidation[63].
On the other hand, several mechanisms are suggested as
probable pathways for paracetamol-mediated nephrotoxicity.
These include the oxidative metabolism to NAPQI similar to that
in the liver, deacetylation to p-aminophenol and further oxida-
tion to an aminophenoxy radical and benzoquinone imine, and
also are the hepatically-derived metabolites from paracetamol–
glutathione conjugates[64].
The elevation in thiobarbituric acid reactive substance level is
an indicator of lipid peroxidation, which has been suggested to
be closely related to paracetamol-induced tissue damage and this
ﬁnding goes hand in hand with our obtained results[65]. It has
been proven that hydrogen peroxide and superoxide anion are
produced during metabolic activation of paracetamol in the
CYP450 system[66] and from mitochondria during paracetamol
intoxication[67]. It has been further suggested that the
generation of ROS appears as an early event which precedes
intracellular glutathione depletion and cell damage in
paracetamol hepatotoxicity.
The superoxide formation may promote peroxynitrite gen-
eration and protein nitration that may further result into oxida-
tive damage to proteins, DNA and lipids[68]. In addition, both
paracetamol and NAPQI can interact with mitochondria,
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decline in ATP content, and uncoupling of the mitochondrial
respiratory chain combined with electron leakage and this
explanation is greatly supported by our ﬁndings[69].
Glutathione is a ubiquitous tripeptide present in all cell types
in millimolar concentrations. The major roles of glutathione
maintain the intracellular redox balance and eliminate xenobi-
otics and ROS[70].
Our results are completely in agreement with Halliwell who
showed that they had chosen the liver, kidney and lung to es-
timate the changes in glutathione because they possess a high
content of this protein[71]. According to the decline in hepatic,
renal and lung glutathione content, it was evident that
paracetamol-induced toxicity involved a change in cellular
redox status toward a state of oxidative stress. A wide variety of
oxidizing molecules such as ROS and/or depleting agents can
alter glutathione redox state, which is normally maintained by
the activity of glutathione-depleting (GPX, GST) and
glutathione-replenishing enzymes. Therefore, it can be assumed
that the decrease in glutathione concentration might cause the
effectiveness of GST and GPX activity to be restricted, as
evident by the intensiﬁcation of lipid peroxidation.
The fall in catalase activity which proven in our results
indicated a decrease in the antioxidative capacity as well. It has
been shown that the decreased activity of SODs may be attrib-
uted to the consumption of these enzymes in ROS detoxiﬁcation
and also it's increasing is due to increased lipid peroxidation. It is
also known that antioxidant enzymes can be inactivated by lipid
peroxides and ROS[72]. SOD is inhibited by hydrogen peroxide,
while GPX and catalase are inhibited by an excess of superoxide
radical on the same grounds as indicated in our study[73].
Lipid peroxidation is supposed to cause the destruction and
damage to cell membranes, lead to changes in membrane
permeability and ﬂuidity and enhance the protein degradation in
mice[74]. In the present study, the levels of lipid peroxidation
were increased, indicating an increase in the generation of free
radicals in the paracetamol treated group and this level was
decreased in other groups treated with silymarin and N. sativa
extract.
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